drugset / Trial / NCT02923817
Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury
Phase 2
Unknown
30 enrolled
Da Nang Hospital
Kitano Hospital · collabTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of study is to determine whether autologous mononuclear cells deriving from the bone marrow are effective in the treatment of spinal cord injury.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-12
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow-derived mononuclear cells | Cell therapy | — | Other |